alexa Non-Occupational Cadmium Exposure is Emerging as a Major Cause of Cancer, Vascular Disorders, and Other Pathologies - A Long-term Controlled Trial of Supplementation with High-Dose Zinc, a Cadmium Antagonist, is Needed | Abstract

Journal of Preventive Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access

Abstract

Epidemiological studies assessing cadmium (Cd) body burden by determining its creatinine-corrected level in urine strongly suggest that non-occupational Cd exposure can boost systemic oxidative stress and inflammation, and is a major mediating factor in the pathogenesis of various common cancers, vascular disease, and other health disorders. Cadmium’s effects in this regard often appear to reflect competition with zinc for binding to regulatory proteins. Indeed, increased intakes of zinc counteract Cd toxicity in rodent models. Zinc’s protective impact in this regard is mediated in part by induction of metallothionein; this sequesters Cd is such a way as to reduce its intestinal absorption and alleviate its pathogenic effects. Zinc’s Cd antagonistic effects may rationalize epidemiology associating increased zinc intakes with lower cancer risks. The significant 27% decrease in total mortality noted in zinc-supplemented subjects (80 mg daily) in the AREDS1 study might also be partially attributable to Cd antagonism. In light of growing evidence that Cd is a major mediator of a number of life-threatening disorders throughout the world, and that zinc can notably lessen its pathogenicity, a large and long-term controlled trial of high-dose zinc supplementation in an older population, with mortality as its primary endpoint, can be strongly recommended. Targeting a population with relatively high Cd exposure, such as that of Japan, would be most appropriate in this regard.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Mark McCarty F James DiNicolantonio J

Keywords

Cadmium, Zinc, Metallothionein, Oxidative stress, Inflammation, Cancer, Cardiovascular disease, Preventive Healthcare,Primary Prevention

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version